Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy was underpowered

Ortiz A, Sanchez-Niño MD

Drug Design, Development and Therapy 2015, 9:5873-5875

Published Date: 2 November 2015